Islet Amyloid Develops Diffusely Throughout the Pancreas before Becoming Severe and Replacing Endocrine Cells

Diabetes

Volumn 50, Issue 7-12, 2001, Pages 2514-2520

  Wang, Feng ^a   Hull, Rebecca L ^a   Vidal, Josep ^a   Cnop, Miriam ^a   Kahn, Steven E ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AMYLOID; GLUCOSE;

ANIMAL; ARTICLE; GENETICS; HUMAN; METABOLISM; MOUSE; PANCREAS; PANCREAS ISLET; PATHOLOGY; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

AMYLOID; ANIMALS; GLUCOSE; HUMANS; ISLETS OF LANGERHANS; MICE; MICE, TRANSGENIC; PANCREAS; TISSUE DISTRIBUTION;

EID: 0035514444     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.11.2514     Document Type: Article

References (27)

1. Westermark P, Wilander E: The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 15:417-421, 1978
2. Röcken C, Linke RP, Saeger W: Immunohistology of islet amyloid polypeptide in diabetes mellitus: semi-quantitative studies in a post-mortem series. Virchows Arch A Pathol Anat Histopathol 421:339-344, 1992
3. Johnson KH, O'Brien TD, Jordan K, Westermark P: Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells. Am J Pathol 135:245-250, 1989
4. Howard CF Jr: Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia 29:301-306, 1986
5. Howard CF Jr, Van Bueren A: Changes in islet cell composition during development of diabetes in Macaca nigra. Diabetes 35:165-171, 1986
6. de Koning EJ, Bodkin NL, Hansen BC, Clark A: Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population. Diabetologia 36:378-384, 1993
7. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH: Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islets. Proc Natl Acad Sci U S A 84:3881-3885, 1987
8. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM: Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A 84:8628-8632, 1987
9. Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ Jr, Porte D Jr: Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells. Diabetes 39:634-638, 1990
10. Lorenzo A, Razzaboni B, Weir GC, Yankner BA: Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368: 756-760, 1994
11. Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC: The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48:491-498, 1999
12. Fox N, Schrementi J, Nishi M, Ohagi S, Chan SJ, Heisserman JA, Westermark GT, Leckstrom A, Westermark P, Steiner DF: Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM). FEBS Lett 323:40-44, 1993
13. D'Alessio DA, Verchere CB, Kahn SE, Hoagland V, Baskin DG, Palmiter RD, Ensinck JW: Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes 43:1457-1461, 1994
14. Couce M, Kane LA, O'Brien TD, Charlesworth J, Soeller W, McNeish J, Kreutter D, Roche P, Butler PC: Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and β-cell dysfunction. Diabetes 45:1094-1101, 1996
15. Höppener JW, Oosterwijk C, Nieuwenhuis MG, Posthuma G, Thijssen JH, Vroom TM, Ahren B, Lips CJ: Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia 42:427-434, 1999
16. Verchere CB, D'Alessio DA, Palmiter RD, Weir GC, Bonner-Weir S, Baskin DG, Kahn SE: Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci USA 93:3492-3496, 1996
17. vy/a mice expressing human islet amyloid polypeptide. Diabetes 47:743-750, 1998
18. Andrikopoulos S, Verchere CB, Terauchi K, Kadowaki T, Kahn SE: β-Cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes. Diabetes 49:2056-2062, 2000
19. Andrikopoulos S, Verchere CB, Teague JC, Howell WM, Fujimoto WY, Wight TN, Kahn SE: Two novel immortal pancreatic β-cell lines expressing and secreting human islet amyloid polypeptide do not spontaneously develop islet amyloid. Diabetes 48:1902-1970, 1999
20. Kahn SE, Andrikopoulos S, Verchere CB, Wang F, Hull RL, Vidal J: Oophorectomy promotes islet amyloid formation in a transgenic mouse model of type 2 diabetes. Diabetologia 43:1309-1312, 2000
21. Westermark P: Quantitative studies of amyloid in the islets of Langerhans. Upsala J Med Sci 77:91-94, 1972
22. Baetens D, Malaisse-Lagae F, Perrelet A, Orci L: Endocrine pancreas: three-dimensional reconstruction shows two types of islets of Langerhans. Science 206:1323-1325, 1979
23. Clark A, Holman RR, Matthews DR, Hockaday TD, Turner RC: Non-uniform distribution of islet amyloid in the pancreas of 'maturity-onset' diabetic patients. Diabetologia 27:527-528, 1984
24. Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJS, Holman RR, Turner RC: Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 9:151-159, 1988
25. Wang F, Adrian TE, Westermark GT, Ding X, Gasslander T, Permert J: Islet amyloid polypeptide tonally inhibits beta-, alpha-, and delta-cell secretion in isolated rat pancreatic islets. Am J Physiol 270: E19-E24, 1999
26. Leighton B, Cooper GJS: Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335:632-635, 1988
27. Verchere CB, D'Alessio DA, Palmiter RD, Kahn SE: Transgenic mice overproducing human islet amyloid polypeptide have increased insulin storage and secretion. Diabetologia 37:725-728, 1994